| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | EVP, General Counsel | SVP, General Counsel
2 companies
David T Howton is Chief Operating Officer at SLDB, with reported holdings spanning 2 companies. From February 2016 to February 2026, the filings on record show 0 open-market purchases and 15 sales. David T Howton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.3M at current prices.
Our model assigns David T Howton a below-average insider score of 34/100, based on 7 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -34.8%.
David T Howton's largest disclosed position is in SLDB as Chief Operating Officer, worth about $660K. The SLDB filings lean toward selling, a net 85,066 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 30,000 | $140.00 | $4,200,000.00 | -60.5% | |
| Jul 16, 2018 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 50,000 | $136.46 | $6,823,000.00 | -58.9% | |
| Jul 20, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 25,000 | $41.00 | $1,025,000.00 | -52.9% | |
| Sep 22, 2016 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 7,000 | $60.00 | $420,000.00 | -24.6% | |
| Sep 19, 2016 | SRPT Sarepta Therapeutics, Inc. | SVP, General Counsel | Sale+OE | 9,304 | $50.00 | $465,200.00 | -30.3% |